LT2624865T - Stabilizuotos kompozicijos turinčios savo sudėtyje antikūnus prieš interleukino 4 receptorių (il-4r) - Google Patents

Stabilizuotos kompozicijos turinčios savo sudėtyje antikūnus prieš interleukino 4 receptorių (il-4r)

Info

Publication number
LT2624865T
LT2624865T LTEP11770625.9T LT11770625T LT2624865T LT 2624865 T LT2624865 T LT 2624865T LT 11770625 T LT11770625 T LT 11770625T LT 2624865 T LT2624865 T LT 2624865T
Authority
LT
Lithuania
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
LTEP11770625.9T
Other languages
English (en)
Lithuanian (lt)
Inventor
Daniel Dix
Xiaolin Tang
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Priority claimed from PCT/US2011/054856 external-priority patent/WO2012047954A1/en
Publication of LT2624865T publication Critical patent/LT2624865T/lt

Links

LTEP11770625.9T 2010-10-06 2011-10-05 Stabilizuotos kompozicijos turinčios savo sudėtyje antikūnus prieš interleukino 4 receptorių (il-4r) LT2624865T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
PCT/US2011/054856 WO2012047954A1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
LT2624865T true LT2624865T (lt) 2018-10-25

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP11770625.9T LT2624865T (lt) 2010-10-06 2011-10-05 Stabilizuotos kompozicijos turinčios savo sudėtyje antikūnus prieš interleukino 4 receptorių (il-4r)

Country Status (13)

Country Link
AR (1) AR083338A1 (da)
DK (2) DK3354280T3 (da)
ES (2) ES2820246T3 (da)
HR (1) HRP20181822T1 (da)
HU (1) HUE052089T2 (da)
LT (1) LT2624865T (da)
PT (1) PT3354280T (da)
RS (1) RS57850B1 (da)
SI (1) SI2624865T1 (da)
SM (1) SMT201800488T1 (da)
TW (7) TWI679988B (da)
UA (1) UA111731C2 (da)
UY (1) UY33652A (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9574004B2 (en) 2012-08-21 2017-02-21 Sanofi Biotechnology Methods for treating or preventing asthma by administering an IL-4R antagonist
TWI707694B (zh) * 2013-06-21 2020-10-21 法商賽諾菲生物技術公司 Il-4r拮抗劑用於製造治療鼻息肉症的藥物之用途
CN111437387B (zh) * 2013-06-21 2024-10-01 赛诺菲生物技术公司 通过施用il-4r拮抗剂治疗鼻息肉症的方法
AU2015346150B2 (en) 2014-11-14 2021-08-19 Regeneron Pharmaceuticals, Inc. Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
CA3079946A1 (en) 2017-10-30 2019-05-09 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
BR112022000740A2 (pt) 2019-07-16 2022-07-05 Sanofi Biotechnology Métodos para tratamento ou prevenção de asma por administração de um antagonista de il-4r

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
KR101593726B1 (ko) * 2008-09-10 2016-02-18 니혼 엑스란 고교 (주) 가교 아크릴레이트계 섬유 및 이의 제조방법
AU2010221156A1 (en) * 2009-03-06 2011-09-22 Genentech, Inc. Antibody formulation

Also Published As

Publication number Publication date
HK1258305A1 (en) 2019-11-08
AR083338A1 (es) 2013-02-21
UY33652A (es) 2012-04-30
UA111731C2 (uk) 2016-06-10
HUE052089T2 (hu) 2021-04-28
TW201542229A (zh) 2015-11-16
TW201221141A (en) 2012-06-01
RS57850B1 (sr) 2018-12-31
TW202102262A (zh) 2021-01-16
SMT201800488T1 (it) 2018-11-09
TW202320851A (zh) 2023-06-01
DK2624865T3 (da) 2018-10-22
TWI718890B (zh) 2021-02-11
PT3354280T (pt) 2020-09-01
DK3354280T3 (da) 2020-09-28
TWI568445B (zh) 2017-02-01
ES2687813T3 (es) 2018-10-29
TWI679988B (zh) 2019-12-21
TW202026011A (zh) 2020-07-16
TWI782325B (zh) 2022-11-01
TW201716086A (zh) 2017-05-16
ES2820246T3 (es) 2021-04-20
TWI498121B (zh) 2015-09-01
HRP20181822T1 (hr) 2018-12-28
TWI690329B (zh) 2020-04-11
TWI856388B (zh) 2024-09-21
SI2624865T1 (sl) 2018-10-30
TW201924718A (zh) 2019-07-01

Similar Documents

Publication Publication Date Title
IL283424B1 (en) Stabilized formulations that include antibodies against the interleukin receptor (il-4r)
PH12012501370A1 (en) Stabilized formulations containing anti-interleukin -6- receptor (il-6r) antibodies
IL265501A (en) Stabilized liquid formulations containing antibody
SI3409289T1 (sl) Stabilni sestavki, ki vsebujejo protitelo
IL223014A0 (en) High concentration antibody formulations
EP2588141A4 (en) ANTIBODY FORMULATIONS
SMT201800488T1 (it) Formulazioni stabilizzate contenenti anticorpi anti-recettore interleuchina-4 (il-4r)